SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000927016-02-005101
Filing Date
2002-10-29
Accepted
2002-10-29 16:51:37
Documents
8
Period of Report
2002-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1033760
3 BINDING MEMORANDUM OF UNDERSTANDING dex1024.txt EX-10.24 58239
4 SUBSIDIARIES OF ALEXION PHARMACEUTICALS dex211.txt EX-21.1 307
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.txt EX-23.1 595
6 CERTIFICATIONS dex991.txt EX-99.1 2743
7 RISK FACTORS dex992.txt EX-99.2 36780
8 REPORT PREVIOUSLY ISSUED BY ARTHUR ANDERSEN dex993.txt EX-99.3 2614
9 GRAPHIC g30139g90j85.jpg GRAPHIC 44754
  Complete submission text file 0000927016-02-005101.txt   1182136
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-27756 | Film No.: 02801692
SIC: 2834 Pharmaceutical Preparations